previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | next
| CSGID ID | Priority | Locus Tag | NCBI GI | Gene Name |
Common Name | Sequence Length |
Comment | Project | Homolog PDB ID |
Homolog Sequence Identity |
Target Organism | TIGR Main Role | TIGR Subrole | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IDP00781 | 1 | SACOL0845 | 57284307 | est | carboxylesterase | 246 | Conserved Gene / Pathway | March 2008 | 1R1D | 57.7% | Staphylococcus aureus | Cellular processes | Detoxification | |||||||||||||||||
| IDP00782 | 1 | SACOL0857 | 57284318 | staphylocoagulase precursor, putative | 508 | Conserved Gene / Pathway | March 2008 | 2A1D | 16.9% | Staphylococcus aureus | Cellular processes | Pathogenesis | ||||||||||||||||||
| IDP00783 | 1 | SACOL0885 | 57284344 | pathogenicity island protein, integrase ... | 406 | Conserved Gene / Pathway | March 2008 | 2A3V | 11.1% | Staphylococcus aureus | Cellular processes | Pathogenesis | ||||||||||||||||||
| IDP00784 | 1 | SACOL0896 | 57284355 | pathogenicity island protein | 289 | Conserved Gene / Pathway | March 2008 | Staphylococcus aureus | Cellular processes | Pathogenesis | ||||||||||||||||||||
| IDP00785 | 1 | SACOL0904 | 57285780 | pathogenicity island protein | 175 | Conserved Gene / Pathway | March 2008 | Staphylococcus aureus | Cellular processes | Pathogenesis | ||||||||||||||||||||
| IDP00786 | 1 | SACOL0899 | 57285775 | pathogenicity island protein | 94 | Conserved Gene / Pathway | March 2008 | Staphylococcus aureus | Cellular processes | Pathogenesis | ||||||||||||||||||||
| IDP00787 | 1 | SACOL1016 | 57284388 | fabI | enoyl-(acyl carrier protein) reductase | 256 | Drug Target Function | March 2008 | 2QIO | 62.5% | Staphylococcus aureus | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00788 | 1 | SACOL1043 | 57284414 | glycosyl transferase, group 1 family pro... | 493 | Conserved Gene / Pathway | March 2008 | 2JJM | 16.2% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP00789 | 1 | SACOL1066 | 57284436 | fmt protein | 397 | Conserved Gene / Pathway | March 2008 | 2QMI | 16.1% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00790 | 1 | SACOL1103 | 57285889 | pdhB | pyruvate dehydrogenase complex E1 compon... | 325 | Drug Target Function | March 2008 | 1W85 | 75.4% | Staphylococcus aureus | Energy metabolism | Pyruvate dehydrogenase | |||||||||||||||||
| IDP00791 | 1 | SACOL1178 | 57284463 | superantigen-like protein | 238 | Virulence Associated Factor | March 2008 | 1M4V | 23.9% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00792 | 1 | SACOL1179 | 57284464 | superantigen-like protein | 241 | Virulence Associated Factor | March 2008 | 1ET9 | 22.8% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00793 | 1 | SACOL1180 | 57284465 | superantigen-like protein | 241 | Virulence Associated Factor | March 2008 | 2R61 | 25.7% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00794 | 1 | SACOL1194 | 57284479 | pbp1 | penicillin-binding protein 1 | 744 | Drug Target Function | March 2008 | 1PYY | 30.9% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00795 | 1 | SACOL1213 | 57285956 | pyrC | dihydroorotase | 424 | Drug Target Function | March 2008 | 1XRF | 42.7% | Staphylococcus aureus | Purines, pyrimidines, nucleosides, and nucleotides | Pyrimidine ribonucleotide biosynthesis | |||||||||||||||||
| IDP00796 | 1 | SACOL1244 | 57285984 | fabD | malonyl CoA-acyl carrier protein transac... | 308 | Drug Target Function | March 2008 | 3EZO | 38.6% | Staphylococcus aureus | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00797 | 1 | SACOL1250 | 57285989 | chromosome segregation SMC protein, puta... | 1188 | Conserved Gene / Pathway | March 2008 | 1W1W | 7.5% | Staphylococcus aureus | Cellular processes | Cell division | ||||||||||||||||||
| IDP00798 | 1 | SACOL1368 | 57284523 | kataA | catalase | 473 | Conserved Gene / Pathway | March 2008 | 2ISA | 63.2% | Staphylococcus aureus | Cellular processes | Detoxification | |||||||||||||||||
| IDP00799 | 1 | SACOL1403 | 57284557 | trpE | anthranilate synthase component I | 468 | Drug Target Function | March 2008 | 1QDL | 33.3% | Staphylococcus aureus | Amino acid biosynthesis | Aromatic amino acid family | |||||||||||||||||
| IDP00800 | 1 | SACOL1419 | 57286070 | oligoendopeptidase F, putative | 604 | Drug Target Function | March 2008 | 2QR4 | 23.8% | Staphylococcus aureus | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP00801 | 1 | SACOL1522 | 57284622 | elastin binding protein, putative | 486 | Conserved Gene / Pathway | March 2008 | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||||
| IDP00802 | 1 | SACOL1704 | 57284716 | mreC | rod shape-determining protein MreC | 280 | Conserved Gene / Pathway | March 2008 | 2J5U | 29.6% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00803 | 1 | SACOL1759 | 57286194 | universal stress protein family | 166 | Conserved Gene / Pathway | March 2008 | 1TQ8 | 30.7% | Staphylococcus aureus | Cellular processes | Adaptations to atypical conditions | ||||||||||||||||||
| IDP00804 | 1 | SACOL1787 | 57286221 | bifunctional 3-deoxy-7-phosphoheptulonat... | 363 | Drug Target Function | March 2008 | 1RZM | 39.9% | Staphylococcus aureus | Amino acid biosynthesis | Aromatic amino acid family | ||||||||||||||||||
| IDP00805 | 1 | SACOL1801 | 57286235 | dipeptidase PepV | 469 | Drug Target Function | March 2008 | 1LFW | 35.2% | Staphylococcus aureus | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP00806 | 1 | SACOL1861 | 57284782 | hsdS | type I restriction-modification enzyme, ... | 399 | Drug Target Function | March 2008 | 1YF2 | 29.1% | Staphylococcus aureus | DNA metabolism | Restriction/modification | |||||||||||||||||
| IDP00807 | 1 | SACOL1865 | 57284786 | serine protease SplE, putative | 238 | Drug Target Function | March 2008 | 2VID | 44.5% | Staphylococcus aureus | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP00808 | 1 | SACOL1868 | 57284789 | splB | serine protease SplB | 240 | Drug Target Function | March 2008 | 2VID | 85% | Staphylococcus aureus | Protein fate | Degradation of proteins, peptides, and glycopeptides | |||||||||||||||||
| IDP00809 | 1 | SACOL1869 | 57284790 | splA | serine protease SplA | 238 | Drug Target Function | March 2008 | 2AS9 | 44.1% | Staphylococcus aureus | Protein fate | Degradation of proteins, peptides, and glycopeptides | |||||||||||||||||
| IDP00810 | 1 | SACOL1870 | 57284791 | hypothetical protein SACOL1870 | 188 | Conserved Gene / Pathway | March 2008 | Staphylococcus aureus | 0 | 0 | ||||||||||||||||||||
| IDP00811 | 1 | SACOL1873 | 57284794 | epiF | epidermin immunity protein F | 230 | Conserved Gene / Pathway | March 2008 | 2IT1 | 34.3% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | |||||||||||||||||
| IDP00812 | 1 | SACOL1881 | 57284801 | lukE | leukotoxin LukE | 311 | Virulence Associated Factor | March 2008 | 2QK7 | 65.9% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | |||||||||||||||||
| IDP00813 | 1 | SACOL2004 | 57284879 | leukocidin subunit precursor, putative | 290 | Conserved Gene / Pathway | March 2008 | 1LKF | 41.4% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00814 | 1 | SACOL2006 | 57284880 | Aerolysin/Leukocidin family protein | 351 | Conserved Gene / Pathway | March 2008 | 2QK7 | 28.5% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00815 | 1 | SACOL2010 | 57284882 | iron compound ABC transporter, iron comp... | 303 | Conserved Gene / Pathway | March 2008 | 2PHZ | 24.1% | Staphylococcus aureus | Cell envelope | Other | ||||||||||||||||||
| IDP00816 | 1 | SACOL2061 | 57284929 | acpS | holo-(acyl-carrier-protein) synthase | 119 | Drug Target Function | March 2008 | 3F09 | 100% | Staphylococcus aureus | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00817 | 1 | SACOL2098 | 57286314 | atpH | ATP synthase F1, delta subunit | 179 | Drug Target Function | March 2008 | Staphylococcus aureus | Energy metabolism | ATP-proton motive force interconversion | |||||||||||||||||||
| IDP00818 | 1 | SACOL2148 | 57286362 | PTS system, mannitol-specific IIA compon... | 144 | Drug Target Function | March 2008 | 1A3A | 34.7% | Staphylococcus aureus | Transport and binding proteins | Carbohydrates, organic alcohols, and acids | ||||||||||||||||||
| IDP00819 | 1 | SACOL2161 | 57286374 | UTP-glucose-1-phosphate uridylyltransfer... | 395 | Conserved Gene / Pathway | March 2008 | 1JV1 | 35.9% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP00820 | 1 | SACOL2167 | 57286380 | iron compound ABC transporter, iron comp... | 327 | Conserved Gene / Pathway | March 2008 | 2CHU | 23.2% | Staphylococcus aureus | Cell envelope | Other | ||||||||||||||||||
| IDP00821 | 1 | SACOL2194 | 57284976 | hysA | hyaluronate lyase | 807 | Conserved Gene / Pathway | March 2008 | 1F1S | 35.1% | Staphylococcus aureus | Cellular processes | Pathogenesis | |||||||||||||||||
| IDP00822 | 1 | SACOL2253 | 57285032 | femX | femX protein | 421 | Conserved Gene / Pathway | March 2008 | 1LRZ | 27.3% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00823 | 1 | SACOL2409 | 57285140 | fmhA | fmhA protein | 416 | Drug Target Function | March 2008 | 1LRZ | 43.3% | Staphylococcus aureus | Cell envelope | Other | |||||||||||||||||
| IDP00824 | 1 | SACOL2418 | 57285148 | IgG-binding protein SBI | 436 | Conserved Gene / Pathway | March 2008 | 2JVG | 15.8% | Staphylococcus aureus | Cellular processes | Pathogenesis | ||||||||||||||||||
| IDP00825 | 1 | SACOL2421 | 57285151 | hlgC | gamma hemolysin, component C | 315 | Conserved Gene / Pathway | March 2008 | 1T5R | 73.3% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | |||||||||||||||||
| IDP00826 | 1 | SACOL2422 | 57285152 | hlgB | gamma hemolysin, component B | 325 | Conserved Gene / Pathway | March 2008 | 1LKF | 92% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | |||||||||||||||||
| IDP00827 | 1 | SACOL2507 | 57285192 | sarU | staphylococcal accessory regulator U | 247 | Conserved Gene / Pathway | March 2008 | 1P4X | 37.7% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | |||||||||||||||||
| IDP00828 | 1 | SACOL2508 | 57285193 | galU | UTP-glucose-1-phosphate uridylyltransfer... | 288 | Conserved Gene / Pathway | March 2008 | 2UX8 | 52.1% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | |||||||||||||||||
| IDP00829 | 1 | SACOL2515 | 57285199 | gntK | gluconokinase | 517 | Drug Target Function | March 2008 | 1R59 | 25.7% | Staphylococcus aureus | Energy metabolism | Sugars | |||||||||||||||||
| IDP00830 | 1 | SACOL2544 | 57285226 | sdaAA | L-serine dehydratase, iron-sulfur-depend... | 299 | Conserved Gene / Pathway | March 2008 | Staphylococcus aureus | Energy metabolism | Amino acids and amines | |||||||||||||||||||
| IDP00831 | 0 | SACOL2545 | 57285227 | sdaAB | L-serine dehydratase, iron-sulfur-depend... | 226 | Conserved Gene / Pathway | March 2008 | Staphylococcus aureus | Energy metabolism | Amino acids and amines | |||||||||||||||||||
| IDP00832 | 1 | SACOL2612 | 57286517 | hydrolase, CocE/NonD family | 560 | Drug Target Function | March 2008 | 1JU3 | 27% | Staphylococcus aureus | Unknown function | Enzymes of unknown specificity | ||||||||||||||||||
| IDP00833 | 1 | SACOL2627 | 57286532 | betA | choline dehydrogenase | 569 | Conserved Gene / Pathway | March 2008 | 2JBV | 32.5% | Staphylococcus aureus | Cellular processes | Adaptations to atypical conditions | |||||||||||||||||
| IDP00834 | 1 | SACOL2670 | 57286574 | glycosyl transferase, group 1 family pro... | 502 | Conserved Gene / Pathway | March 2008 | 2JJM | 10.2% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP00835 | 1 | SACOL2685 | 57286588 | cap1C | capsular polysaccharide biosynthesis pro... | 255 | Conserved Gene / Pathway | March 2008 | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | |||||||||||||||||||
| IDP00836 | 1 | SACOL2714 | 57285268 | pcp | pyrrolidone-carboxylate peptidase | 212 | Drug Target Function | March 2008 | 1AUG | 42.9% | Staphylococcus aureus | Protein fate | Degradation of proteins, peptides, and glycopeptides | |||||||||||||||||
| IDP00837 | 1 | SACOL2735 | 57285289 | chromosome partioning protein, ParB fami... | 279 | Conserved Gene / Pathway | March 2008 | 1VZ0 | 31.2% | Staphylococcus aureus | Cellular processes | Cell division | ||||||||||||||||||
| IDP00838 | 1 | SACOL0833 | 57284295 | clpP | ATP-dependent Clp protease, proteolytic ... | 195 | Drug Target Function | March 2008 | 2ZL0 | 65.1% | Staphylococcus aureus | Protein fate | Degradation of proteins, peptides, and glycopeptides | |||||||||||||||||
| IDP00839 | 1 | SACOL1328 | 57284485 | glnR | glutamine synthetase repressor | 122 | Conserved Gene / Pathway | March 2008 | 1JBG | 23.8% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | |||||||||||||||||
| IDP00840 | 1 | SACOL1894 | 57284813 | HIT family protein | 140 | Drug Target Function | March 2008 | 1Y23 | 52.1% | Staphylococcus aureus | Unknown function | General | ||||||||||||||||||
| IDP00841 | 1 | SACOL0876 | 57284336 | arsenate reductase, putative | 118 | Conserved Gene / Pathway | March 2008 | 1RW1 | 28% | Staphylococcus aureus | Cellular processes | Detoxification | ||||||||||||||||||
| IDP00842 | 1 | SACOL1186 | 57284471 | antibacterial protein (phenol soluble mo... | 44 | Drug Target Function | March 2008 | Staphylococcus aureus | Unknown function | General | ||||||||||||||||||||
| IDP00843 | 1 | SACOL1859 | 57284780 | hypothetical protein SACOL1859 | 1016 | Drug Target Function | March 2008 | Staphylococcus aureus | 0 | 0 | ||||||||||||||||||||
| IDP00844 | 1 | SACOL0519 | 57285544 | acetyltransferase, GNAT family | 174 | Drug Target Function | March 2008 | Staphylococcus aureus | Unknown function | Enzymes of unknown specificity | ||||||||||||||||||||
| IDP00845 | 1 | SACOL0968 | 57285842 | spsA | signal peptidase IA, inactive | 174 | Drug Target Function | March 2008 | Staphylococcus aureus | Protein fate | Protein and peptide secretion and trafficking | |||||||||||||||||||
| IDP00846 | 1 | SACOL1177 | 57284462 | hypothetical protein SACOL1177 | 43 | Drug Target Function | March 2008 | Staphylococcus aureus | 0 | 0 | ||||||||||||||||||||
| IDP00847 | 1 | SACOL1404 | 57284558 | trpG | anthranilate synthase, glutamine amidotr... | 188 | Drug Target Function | March 2008 | 1QDL | 35.1% | Staphylococcus aureus | Amino acid biosynthesis | Aromatic amino acid family | |||||||||||||||||
| IDP00848 | 1 | SACOL1753 | 57286190 | universal stress protein family | 137 | Conserved Gene / Pathway | March 2008 | 1MJH | 38% | Staphylococcus aureus | Cellular processes | Adaptations to atypical conditions | ||||||||||||||||||
| IDP00849 | 1 | SACOL2326 | 57285061 | fosB | fosfomycin resistance protein FosB | 139 | Conserved Gene / Pathway | March 2008 | 1NPB | 39.6% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | |||||||||||||||||
| IDP00850 | 1 | SACOL2389 | 57285120 | transcriptional regulatory protein DegU,... | 217 | Conserved Gene / Pathway | March 2008 | 1A04 | 31.3% | Staphylococcus aureus | Cellular processes | Pathogenesis | ||||||||||||||||||
| IDP00851 | 1 | SACOL2688 | 57286591 | icaR | intercellular adhesion regulator | 186 | Conserved Gene / Pathway | March 2008 | 2ZCN | 65.6% | Staphylococcus aureus | Cellular processes | Pathogenesis | |||||||||||||||||
| IDP00852 | 1 | STM3689 | 16766974 | yibL | hypothetical protein STM3689 | 120 | Conserved Gene / Pathway | March 2008 | Salmonella typhimurium | Protein synthesis | tRNA aminoacylation | |||||||||||||||||||
| IDP00853 | 1 | STM0359 | 16763739 | putative cytoplasmic protein | 33 | Conserved Gene / Pathway | March 2008 | Salmonella typhimurium | Protein synthesis | tRNA aminoacylation | ||||||||||||||||||||
| IDP00854 | 1 | STM1810 | 16765151 | putative cytoplasmic protein | 45 | Conserved Gene / Pathway | March 2008 | Salmonella typhimurium | Protein synthesis | tRNA aminoacylation | ||||||||||||||||||||
| IDP00855 | 1 | STM0146 | 16763536 | ampD | N-acetyl-anhydromuranmyl-L-alanine amida... | 187 | Conserved Gene / Pathway | March 2008 | ||||||||||||||||||||||